Skip to main content
Browse by:

Until further notice, in-person public events have been canceled. This includes recruitment events, tours, student programs, reunions, performances, conferences and social events.
Event listings include how to access online content. Contact event sponsor with questions.
Please note that all visitors to campus must comply with Duke’s community safety measures, which include wearing a mask,
check before coming to campus, and follow direction provided by campus personnel.

Wrenn Lecture: Can We Detect and Treat Alzheimer's Disease a Decade before Dementia?

Wrenn Lecture with Dr. Relsa A. Sperling
Icon calendar
Thursday, December 13, 2018
Icon time
12:00 pm - 1:00 pm
Icon speaker
Reisa A. Sperling, MD
Icon series
Psychiatry and Behavioral Sciences Grand Rounds

Dr. Reisa Sperling is a neurologist focused on the detection and treatment of Alzheimer's disease, even before clinical symptoms are evident. Her research uses neuroimaging and cognitive tests to understand the aging brain and the earliest changes associated with Alzheimer's disease. Dr. Sperling is a professor in Neurology at Harvard Medical School, and the Director of the Center for Alzheimer Research and Treatment at Brigham and Women's Hospital and Massachusetts General Hospital. Dr. Sperling led the NIA-Alzheimer's Association workgroup to develop guidelines for "Preclinical Alzheimer's disease," and
currently serves on the Advisory Council of the National Institute on Aging. She
is the co-Principal Investigator, with Dr. Keith Johnson, of the Harvard Aging Brain Study in Boston. Dr. Sperling is the Project Leader for the Anti-Amyloid Treatment in Asymptomatic Alzheimer's disease (A4) study - a landmark secondary prevention trial in over 1150 clinically normal older individuals with PET amyloid imaging evidence of early Alzheimer's disease pathology. She is the co-Principal Investigator of the newly NIH funded Alzheimer's Disease Clinical
Trial Consortium (ACTC). Dr. Sperling has received the 2011 Derek Denny-Brown
Young Neurological Scholar Award, the 2015 American Academy of Neurology Potamkin Prize, and was named one of the 2017 Most Disruptive Women to Watch in Healthcare.

This Grand Rounds event is made possible by the Hans Lowenbach Memorial Fund

Contact: Lamez Williams